Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-02-12 @ 10:19 AM
Study NCT ID:
NCT02937350
Status:
COMPLETED
Last Update Posted:
2021-09-01
First Post:
2016-10-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
Sponsor:
University of Washington
Organization:
Study Overview
Official Title:
Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
Status:
COMPLETED
Status Verified Date:
2021-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CLEAR
Brief Summary:
The goal of this study is to better understand vitamin D catabolism and how it is affected by CKD and race.
Detailed Description:
Specifically, the study team will evaluate the metabolic clearance of 25-hydroxyvitamin D3 in individuals with varying degrees of CKD and among participants who self-report race as Caucasian, African American or African. The long-term goal of this work is to enhance the clinical evaluation and treatment of impaired vitamin D metabolism.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| R01DK099199 | NIH | None | https://reporter.nih.gov/quic… | View |